Traxis Partners’s Tenet Healthcare THC Stock Holding History

Traxis Partners’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-50,000	Closed	-$2.31M	–	30
2013 Q2	$2.31M	Buy	+50,000	New	+$2.24M	1.78%	25

Other funds holding THC

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCOV

London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Traxis Partners's THC Position: Q3 2013 in Review

Traxis Partners sold out of Tenet Healthcare (THC) in Q3 2013, closing a stake of 50,000 shares — an estimated $2.31M sold.

Traxis Partners first reported a position in THC in Q2 2013 and held it in 1 quarter. The position peaked at $2.31M in Q2 2013. 270 funds tracked by Wall St. Rank hold THC as of Q3 2013.

Traxis Partners reported no remaining Tenet Healthcare position as of Q3 2013 after selling out during the quarter.
Traxis Partners sold 50,000 Tenet Healthcare shares in Q3 2013, an estimated $2.31M.
Traxis Partners first reported a position in Tenet Healthcare in Q2 2013 and held it in 1 quarter.
Traxis Partners's Tenet Healthcare position peaked at $2.31M in Q2 2013.
270 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2013.

Based on Traxis Partners's 13F filing for Q3 2013.